Mantovani, A.; Petracca, G.; Beatrice, G.; Csermely, A.; Lonardo, A.; Targher, G.
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. Metabolites 2021, 11, 73.
https://doi.org/10.3390/metabo11020073
AMA Style
Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Targher G.
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. Metabolites. 2021; 11(2):73.
https://doi.org/10.3390/metabo11020073
Chicago/Turabian Style
Mantovani, Alessandro, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, and Giovanni Targher.
2021. "Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials" Metabolites 11, no. 2: 73.
https://doi.org/10.3390/metabo11020073
APA Style
Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., & Targher, G.
(2021). Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. Metabolites, 11(2), 73.
https://doi.org/10.3390/metabo11020073